Anderson Kenneth Carl has filed 12 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 4259 shares of C4 Therapeutics, Inc. ($CCCC) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 4259 | $2.70 | 354,515.0000 | 96,914,418 | 1.22% | 0.00% |
| Jan. 2, 2026 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 5958 | $1.93 | 350,256.0000 | 96,914,418 | 1.73% | 0.01% |
| Oct. 1, 2025 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 5349 | $2.15 | 344,298.0000 | 70,989,661 | 1.58% | 0.01% |
| July 1, 2025 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 7616 | $1.51 | 338,949.0000 | 70,989,661 | 2.30% | 0.01% |
| June 18, 2025 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Stock Option (Right to Buy) | 35500 | $0.00 | 35,500.0000 | 70,989,661 | 9999.99% | 0.05% |
| April 1, 2025 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 7841 | $1.44 | 331,333.0000 | 70,989,661 | 2.42% | 0.01% |
| Jan. 2, 2025 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 3074 | $3.66 | 323,492.0000 | 0 | 0.96% | 0.00% |
| Oct. 1, 2024 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 2023 | $5.56 | 320,418.0000 | 0 | 0.64% | 0.00% |
| July 1, 2024 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 2320 | $4.85 | 318,395.0000 | 0 | 0.73% | 0.00% |
| June 20, 2024 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Stock Option (Right to Buy) | 32500 | $0.00 | 32,500.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 1389 | $8.10 | 316,075.0000 | 0 | 0.44% | 0.00% |
| Jan. 2, 2024 | C4 Therapeutics, Inc. | $CCCC | Anderson Kenneth Carl | Director | A | Common Stock | 1725 | $6.52 | 314,686.0000 | 0 | 0.55% | 0.00% |